![Adam Margolin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adam Margolin
Directeur Général chez NextVivo, Inc.
Profil
Adam Margolin is the founder of NextVivo, Inc. and Flashpoint Therapeutics, Inc. Prior to his current positions, he worked as a Venture Partner at Khosla Ventures LLC.
He received his undergraduate degree from the University of Pennsylvania in 2002.
Postes actifs de Adam Margolin
Sociétés | Poste | Début |
---|---|---|
NextVivo, Inc.
![]() NextVivo, Inc. Packaged SoftwareTechnology Services NextVivo, Inc. is a biotech company based in California that is focused on developing an immune organoid technology platform to accelerate the development of safer and more effective therapies. The American company's mission is to generate and test immune-competent human-derived models that can be used to develop cell and antibody therapies and test immune-modulating drug candidates for a range of diseases, including cancer, infection, and autoimmune disorders. The company was co-founded by Dr. Mark Davis and Dr. Calvin Kuo from Stanford University, and by Dr. Adam Margolin, former chair and professor of genetics and genomic science and senior associate dean. Dr. Adam Margolin has been the CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Adam Margolin
Sociétés | Poste | Fin |
---|---|---|
Khosla Ventures LLC
![]() Khosla Ventures LLC Investment ManagersFinance Khosla Ventures LLC (Khosla Ventures) is a venture capital firm founded in 2004 by Vinod Khosla. The firm is headquartered in Menlo Park, California. | Analyste en capital-investissement | - |
Formation de Adam Margolin
University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Khosla Ventures LLC
![]() Khosla Ventures LLC Investment ManagersFinance Khosla Ventures LLC (Khosla Ventures) is a venture capital firm founded in 2004 by Vinod Khosla. The firm is headquartered in Menlo Park, California. | Finance |
NextVivo, Inc.
![]() NextVivo, Inc. Packaged SoftwareTechnology Services NextVivo, Inc. is a biotech company based in California that is focused on developing an immune organoid technology platform to accelerate the development of safer and more effective therapies. The American company's mission is to generate and test immune-competent human-derived models that can be used to develop cell and antibody therapies and test immune-modulating drug candidates for a range of diseases, including cancer, infection, and autoimmune disorders. The company was co-founded by Dr. Mark Davis and Dr. Calvin Kuo from Stanford University, and by Dr. Adam Margolin, former chair and professor of genetics and genomic science and senior associate dean. Dr. Adam Margolin has been the CEO since incorporation. | Technology Services |